Found 99 matching trials
Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03) PHASE2 To investigate the safety and efficacy of preoperative moderately fractiona...
Show More Location
Beijing Jishuitan Hospital
Learn More & Join Trial
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy PHASE3 The study is being conducted to evaluate the tolerability, safety and effic...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer PHASE2 This is an open-label, multi-center Phase II study of fluzoparib combined w...
Show More Location
Sun Yat-sen University Cancer Cetntre
Learn More & Join Trial
A Trial of SHR3162 in Healthy Caucasian Volunteers PHASE1 The purpose of this study is to assess the safety and PK characteristics of...
Show More Location
Atridia Pty Limited
Learn More & Join Trial
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer PHASE1 The study is being conducted to: a) evaluate the tolerability and safety of...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer PHASE2 The purpose of this clinical trial is to evaluate the efficacy and safety o...
Show More Learn More & Join Trial
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma PHASE2 The current study is an investigator-initiated, single-arm phase 2 study th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi PHASE2 This is a randomized, multicenter, two-arm, noncomparative, phase II study ...
Show More Location
Affiliated Tumor Hospital of Guangxi Medical University.
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial